SLC10A1 and cholestasis: Under specific circumstances, the drug-mediated inhibition of NTCP may protect against cholestasis; for example, bosentan, a dual inhibitor of BSEP and NTCP, was cholestatic in humans but non-cholestatic in rats due to the significantly more potent inhibition of rat Ntcp compared to human NTCP [39].